Glaucoma is a complex eye disease in which nerve damage leads to vision loss and blindness if left untreated. High eye pressure alone does not cause Glaucoma, however high eye pressure has been found to be a significant risk factor for the disease. An estimated 2.2 million Americans are currently living with Glaucoma, and many more are living with High Eye Pressure. Source: http://www.glaucoma.org/glaucoma/
To be contacted by a research team member in your area, please contact us here by submitting your informaiton at the form below.
The Apollo Study is being conducted at local research sites throughout the US.
Before beginning The Apollo Study, you will be screened for eligibility. If you are determined to be eligible, and you agree to participate, you will be randomly placed into one of the dosing groups, with certain groups receiving placebo (an inactive substance).
You and your doctor will not know your dosing group assignment, however in the event of an emergency; this information will be provided to your doctor.
After you join the study, you will begin a 12 to 13 month involvement in the study, which will include 8 or 9 visits to the study clinic. During your visit, you will receive the study drug, as well as have doctors monitor your health and progress through various related tests and assessments.